North Little Rock, ARKANSAS3 Active Studies

Ankylosing Spondylitis Clinical Trials in North Little Rock, ARKANSAS

Find 3 actively recruiting ankylosing spondylitis clinical trials in North Little Rock, ARKANSAS. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
1,912
Enrolling

Recruiting Ankylosing Spondylitis Studies in North Little Rock

About Ankylosing Spondylitis Clinical Trials in North Little Rock

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in North Little Rock, ARKANSAS. These studies are seeking a combined 1,912 participants. Research is being sponsored by 89bio, Inc., Altimmune, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in North Little Rock — FAQ

Are there ankylosing spondylitis clinical trials in North Little Rock?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in North Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in North Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North Little Rock research site will contact you about next steps.

Are clinical trials in North Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North Little Rock studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in North Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov